News
Top Small Cap Negative News Movers Premarket: ABOS: -77% Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) AXG: -31% Mo
Oct 30, 2026 · ThinkSabio Blog
Top Small Cap Negative News Movers Premarket:
ABOS: -77% Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193)
AXG: -31% Momentum Mover
FNGR: -27% Signs Term Sheet for Business Combination with BlueFlare Group Holdings to Form a North American Power-First Digital Infrastructure Company
SNTI: -19% Momentum Mover
30-OCT-2026 08:09 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
